InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
4
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+6.6%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Kelly Timothy Edwin, Chief Financial Officer. Director active across 1 company, notably Praxis Precision Medicines, Inc.. Cumulatively, 20 filings have been published. Split: 4 buys · 0 sell. Total volume traded: €94k. Activity tracked since 31 August 2021. The latest transaction was filed on 12 January 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Kelly Timothy Edwin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
943 shares@ US$275.7451.5% of flowCommon StockSEC:0001863297-26-000005:0
8,800 shares0Common StockSEC:0001689548-26-000011:0
139 shares@ US$292.638.0% of flowCommon StockSEC:0001863297-26-000002:0
384 shares@ US$31.625.9% of flowCommon StockSEC:0001104659-25-115100:0
249 shares@ US$31.5353.1% of flowCommon StockSEC:0001689548-25-000065:0
12,500 shares0Common StockSEC:0001689548-25-000014:0
139 shares@ US$77.524.5% of flowCommon StockSEC:0001689548-25-000005:0
205 shares@ US$37.403.2% of flowCommon StockSEC:0001104659-24-120746:0
7,800 shares0Common StockSEC:0001104659-24-084502:0
606 shares@ US$12.3683.0% of flowCommon StockSEC:0001689548-24-000064:0
139 shares@ US$25.191.4% of flowCommon StockSEC:0001689548-24-000008:0
11,683 shares@ US$0.8844.1% of flowCommon StockSEC:0001689548-23-000092:0
8,000 shares@ US$0.87472.8% of flowCommon StockSEC:0001104659-23-042818:0
Canonical exit: 22 Jun 2023 (T+90)
8,000 shares@ US$0.87472.8% of flowCommon StockSEC:0001104659-23-037021:0
Canonical exit: 22 Jun 2023 (T+90)
2,079 shares@ US$2.522.2% of flowCommon StockSEC:0001689548-23-000005:0
5 shares@ US$1.8110.0% of flowCommon StockSEC:0001689548-22-000129:0
10,000 shares@ US$1.7653.9% of flowCommon StockSEC:0001689548-22-000078:0
Canonical exit: 7 Sept 2022 (T+90)
2,585 shares@ US$8.7985.1% of flowCommon StockSEC:0001689548-22-000042:0
24,000 shares0Common StockSEC:0001104659-22-003155:0
3,905 shares@ US$19.4815.1% of flowCommon StockSEC:0001689548-21-000083:0
Canonical exit: 29 Nov 2021 (T+90)
20 of 20 declarations
About Kelly Timothy Edwin
Kelly Timothy Edwin is Chief Financial Officer at Praxis Precision Medicines, Inc. (XNAS). He has 20 filings in total, and across the 20 recent sampled filings observed between 2021-09-02 and 2026-01-13, buy transactions amount to EUR 93947, with no sells; the most frequent transaction nature is Attribution.
